192 related articles for article (PubMed ID: 37788938)
1. Utility of Acute and Subacute Blood Biomarkers to Assist Diagnosis in CT-Negative Isolated Mild Traumatic Brain Injury.
Reyes J; Spitz G; Major BP; O'Brien WT; Giesler LP; Bain JWP; Xie B; Rosenfeld JV; Law M; Ponsford JL; O'Brien TJ; Shultz SR; Willmott C; Mitra B; McDonald SJ
Neurology; 2023 Nov; 101(20):e1992-e2004. PubMed ID: 37788938
[TBL] [Abstract][Full Text] [Related]
2. Utility of Serum Biomarkers in the Diagnosis and Stratification of Mild Traumatic Brain Injury.
Lewis LM; Schloemann DT; Papa L; Fucetola RP; Bazarian J; Lindburg M; Welch RD
Acad Emerg Med; 2017 Jun; 24(6):710-720. PubMed ID: 28170122
[TBL] [Abstract][Full Text] [Related]
3. Time Course and Diagnostic Accuracy of Glial and Neuronal Blood Biomarkers GFAP and UCH-L1 in a Large Cohort of Trauma Patients With and Without Mild Traumatic Brain Injury.
Papa L; Brophy GM; Welch RD; Lewis LM; Braga CF; Tan CN; Ameli NJ; Lopez MA; Haeussler CA; Mendez Giordano DI; Silvestri S; Giordano P; Weber KD; Hill-Pryor C; Hack DC
JAMA Neurol; 2016 May; 73(5):551-60. PubMed ID: 27018834
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Glial and Neuronal Blood Biomarkers Compared With Clinical Decision Rules in Assessing the Need for Computed Tomography in Patients With Mild Traumatic Brain Injury.
Papa L; Ladde JG; O'Brien JF; Thundiyil JG; Tesar J; Leech S; Cassidy DD; Roa J; Hunter C; Miller S; Baker S; Parrish GA; Davison J; Van Dillen C; Ralls GA; Briscoe J; Falk JL; Weber K; Giordano PA
JAMA Netw Open; 2022 Mar; 5(3):e221302. PubMed ID: 35285924
[TBL] [Abstract][Full Text] [Related]
5. Glial fibrillary acidic protein elevations relate to neuroimaging abnormalities after mild TBI.
Gill J; Latour L; Diaz-Arrastia R; Motamedi V; Turtzo C; Shahim P; Mondello S; DeVoto C; Veras E; Hanlon D; Song L; Jeromin A
Neurology; 2018 Oct; 91(15):e1385-e1389. PubMed ID: 30209234
[TBL] [Abstract][Full Text] [Related]
6. Chronic immunosuppression across 12 months and high ability of acute and subacute CNS-injury biomarker concentrations to identify individuals with complicated mTBI on acute CT and MRI.
Clarke GJB; Follestad T; Skandsen T; Zetterberg H; Vik A; Blennow K; Olsen A; Håberg AK
J Neuroinflammation; 2024 Apr; 21(1):109. PubMed ID: 38678300
[TBL] [Abstract][Full Text] [Related]
7. Association between Blood and Computed Tomographic Imaging Biomarkers in a Cohort of Mild Traumatic Brain Injury Patients.
Chen H; Ding VY; Zhu G; Jiang B; Li Y; Boothroyd D; Rezaii PG; Bet AM; Paulino AD; Weber A; Glushakova OY; Hayes RL; Wintermark M
J Neurotrauma; 2022 Oct; 39(19-20):1329-1338. PubMed ID: 35546284
[TBL] [Abstract][Full Text] [Related]
8. Glial Fibrillary Acidic Protein (GFAP) Outperforms S100 Calcium-Binding Protein B (S100B) and Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) as Predictor for Positive Computed Tomography of the Head in Trauma Subjects.
Mahan MY; Thorpe M; Ahmadi A; Abdallah T; Casey H; Sturtevant D; Judge-Yoakam S; Hoover C; Rafter D; Miner J; Richardson C; Samadani U
World Neurosurg; 2019 Aug; 128():e434-e444. PubMed ID: 31051301
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Utility of Glial Fibrillary Acidic Protein Beyond 12 Hours After Traumatic Brain Injury: A TRACK-TBI Study.
Puccio AM; Yue JK; Korley FK; Okonkwo DO; Diaz-Arrastia R; Yuh EL; Ferguson AR; Mukherjee P; Wang KKW; Taylor SR; Deng H; Markowitz AJ; Sun X; Jain S; Manley GT
J Neurotrauma; 2024 Jun; 41(11-12):1353-1363. PubMed ID: 38251868
[TBL] [Abstract][Full Text] [Related]
10. Time course and diagnostic utility of NfL, tau, GFAP, and UCH-L1 in subacute and chronic TBI.
Shahim P; Politis A; van der Merwe A; Moore B; Ekanayake V; Lippa SM; Chou YY; Pham DL; Butman JA; Diaz-Arrastia R; Zetterberg H; Blennow K; Gill JM; Brody DL; Chan L
Neurology; 2020 Aug; 95(6):e623-e636. PubMed ID: 32641529
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 Using a Rapid Point of Care Test for Predicting Head Computed Tomography Lesions After Mild Traumatic Brain Injury in a Dutch Multi-Center Cohort.
Chayoua W; Visser K; de Koning ME; Beishuizen A; IJmker R; van der Naalt J; Krabbe JG; van der Horn HJ
J Neurotrauma; 2024 Feb; ():. PubMed ID: 38326742
[TBL] [Abstract][Full Text] [Related]
12. Cost-Effectiveness of Blood-Based Brain Biomarkers for Screening Adults with Mild Traumatic Brain Injury in the French Health Care Setting.
Zimmer L; McDade C; Beyhaghi H; Purser M; Textoris J; Krause A; Blanc E; Pavlov V; Earnshaw S
J Neurotrauma; 2023 Apr; 40(7-8):706-719. PubMed ID: 36267001
[TBL] [Abstract][Full Text] [Related]
13. Sex differences in time course and diagnostic accuracy of GFAP and UCH-L1 in trauma patients with mild traumatic brain injury.
Papa L; Brophy GM; Alvarez W; Hirschl R; Cress M; Weber K; Giordano P
Sci Rep; 2023 Jul; 13(1):11833. PubMed ID: 37481589
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort study.
Korley FK; Jain S; Sun X; Puccio AM; Yue JK; Gardner RC; Wang KKW; Okonkwo DO; Yuh EL; Mukherjee P; Nelson LD; Taylor SR; Markowitz AJ; Diaz-Arrastia R; Manley GT;
Lancet Neurol; 2022 Sep; 21(9):803-813. PubMed ID: 35963263
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal Associations Between Persistent Post-Concussion Symptoms and Blood Biomarkers of Inflammation and CNS-Injury After Mild Traumatic Brain Injury.
Clarke GJB; Skandsen T; Zetterberg H; Follestad T; Einarsen CE; Vik A; Mollnes TE; Pischke SE; Blennow K; Håberg AK
J Neurotrauma; 2024 Apr; 41(7-8):862-878. PubMed ID: 38117157
[TBL] [Abstract][Full Text] [Related]
16. Study protocol for investigating the clinical performance of an automated blood test for glial fibrillary acidic protein and ubiquitin carboxy-terminal hydrolase L1 blood concentrations in elderly patients with mild traumatic BRAIN Injury and reference values (BRAINI-2 Elderly European study): a prospective multicentre observational study.
Lagares A; Payen JF; Biberthaler P; Poca MA; Méjan O; Pavlov V; Viglino D; Sapin V; Lassaletta A; de la Cruz J;
BMJ Open; 2023 Jul; 13(7):e071467. PubMed ID: 37460257
[TBL] [Abstract][Full Text] [Related]
17. Study protocol for investigating the performance of an automated blood test measuring GFAP and UCH-L1 in a prospective observational cohort of patients with mild traumatic brain injury: European BRAINI study.
Richard M; Lagares A; Bondanese V; de la Cruz J; Mejan O; Pavlov V; Payen JF;
BMJ Open; 2021 Feb; 11(2):e043635. PubMed ID: 33632753
[TBL] [Abstract][Full Text] [Related]
18. The Levels of Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 During the First Week After a Traumatic Brain Injury: Correlations With Clinical and Imaging Findings.
Posti JP; Takala RS; Runtti H; Newcombe VF; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Coles JP; Hossain MI; Kyllönen A; Maanpää HR; Tallus J; Hutchinson PJ; van Gils M; Menon DK; Tenovuo O
Neurosurgery; 2016 Sep; 79(3):456-64. PubMed ID: 26963330
[TBL] [Abstract][Full Text] [Related]
19. Association of Blood Biomarkers With Acute Sport-Related Concussion in Collegiate Athletes: Findings From the NCAA and Department of Defense CARE Consortium.
McCrea M; Broglio SP; McAllister TW; Gill J; Giza CC; Huber DL; Harezlak J; Cameron KL; Houston MN; McGinty G; Jackson JC; Guskiewicz K; Mihalik J; Brooks MA; Duma S; Rowson S; Nelson LD; Pasquina P; Meier TB; ; Foroud T; Katz BP; Saykin AJ; Campbell DE; Svoboda SJ; Goldman J; DiFiori J
JAMA Netw Open; 2020 Jan; 3(1):e1919771. PubMed ID: 31977061
[TBL] [Abstract][Full Text] [Related]
20. S100B, GFAP, UCH-L1 and NSE as predictors of abnormalities on CT imaging following mild traumatic brain injury: a systematic review and meta-analysis of diagnostic test accuracy.
Amoo M; Henry J; O'Halloran PJ; Brennan P; Husien MB; Campbell M; Caird J; Javadpour M; Curley GF
Neurosurg Rev; 2022 Apr; 45(2):1171-1193. PubMed ID: 34709508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
